CVS Maximum Redness Relief
- Manufacturer
- CVS Pharmacy, Inc. | KC Pharmaceuticals, Inc.
- Effective date
- 2025-12-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 01:30:52
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredients
Active ingredients
Glycerin 0.5%
Naphazoline hydrochloride 0.03%
OTC - PURPOSE SECTION
Purposes
Glycerin....Lubricant
Naphazoline HCl....Redness Reliever
INDICATIONS & USAGE SECTION
Uses
• for the relief of redness of the eye due to minor eye irritations
• for the temporary relief of burning and irritation due to dryness of the eye
• for use as a protectant against further irritation or dryness of the eye
Warnings
For external use only
Do not use
Do not use if solution changes color or becomes cloudy
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have narrow angle glaucoma
OTC - WHEN USING SECTION
When using this product
• to avoid contamination, do not touch tip of container to any surface
• replace cap after using
• overuse may produce increased redness of the eye
• pupils may become enlarged temporarily
OTC - STOP USE SECTION
Stop use and ask a doctor if
• you experience eye pain
• you experience changes in vision
• you experience continued redness or irritation of the eye
• the condition worsens or persists for more than 72 hours
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
DOSAGE & ADMINISTRATION SECTION
Directions
instill 1 or 2 drops in the affected eye(s) up to 4 times daily.
OTHER SAFETY INFORMATION
Other information
• store at room temperature
• remove contact lenses before using
INACTIVE INGREDIENT SECTION
Inactive ingredients
benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| e18001c8-33ae-5f66-9cdc-a39724bd4573 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51316-837-01 | CVS Maximum Redness Relief | 15 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 15 | 3 | |
| 51316-837-01 | CVS Maximum Redness Relief | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 3 |
Products#
Every source-derived product name is available through these pages.
- CVS Maximum Redness Relief
- Glycerin, Naphazoline HCI
- NAPHAZOLINE HYDROCHLORIDE
- NAPHAZOLINE
- BORIC ACID
- GLYCERIN
- BENZALKONIUM CHLORIDE
- EDETATE DISODIUM
- EDETIC ACID
- WATER
- SODIUM BORATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 51316-837 | 51316-837-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| BORIC ACID | R57ZHV85D4 | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Maximum Redness Relief | GLYCERIN, NAPHAZOLINE HCI | CVS Pharmacy, Inc. | f70f9fc4-4022-336e-e053-6394a90a4d07 | 2025-12-30 | Warnings | 51316-837-01 51316-837 51316083701 474514b6-e7c8-a448-e063-6394a90a459f f70f9fc4-4022-336e-e053-6394a90a4d07 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
